Patents by Inventor Chae Won Park

Chae Won Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11968779
    Abstract: A flexible printed circuit board according to an embodiment includes: a substrate; a circuit pattern disposed on the substrate; and a protective layer on the circuit pattern, wherein the circuit pattern includes a first circuit pattern and a second circuit pattern connected to a chip in a chip mounting region, a first direction that is a direction in which the circuit pattern extends and a second direction perpendicular to the first direction are defined in the substrate, the substrate includes first and second ends facing each other in the first direction and third and fourth ends facing each other in the second direction, the protective layer includes fifth and sixth ends spaced apart from ends of the substrate and facing in the first direction and seventh and eighth ends spaced apart from ends of the substrate and facing in the second direction, and an outer pattern disposed adjacent to the third end and the fourth end on the substrate, wherein the outer pattern includes: a first outer pattern and a second
    Type: Grant
    Filed: September 20, 2022
    Date of Patent: April 23, 2024
    Assignee: LG INNOTEK CO., LTD.
    Inventors: Ki Tae Park, Chae Won Kang, Man Ki Son
  • Publication number: 20240092974
    Abstract: The present disclosure relates to a polyimide-based resin film comprising a polyimide-based resin containing a polyimide repeating unit represented by Chemical Formula 1 and a polyimide repeating unit represented by Chemical Formula 2, a substrate for display device, and an optical device using the same.
    Type: Application
    Filed: September 14, 2022
    Publication date: March 21, 2024
    Applicant: LG CHEM, LTD.
    Inventors: Mi Eun KANG, Chan Hyo PARK, Jinyoung PARK, Chae Won PARK, Min Wook LEE
  • Patent number: 11915875
    Abstract: A multilayer electronic component includes: a body including a dielectric layer and a plurality of internal electrodes alternately disposed with the dielectric layer; and external electrodes disposed on the body, wherein the external electrodes respectively include an electrode layer disposed on the body and connected to the plurality of internal electrodes and a conductive resin layer disposed on the electrode layer and including a first conductive particle, a second conductive particle, and a resin, wherein the first conductive particle is a Cu particle, the second conductive particle is a Cu particle having a surface on which Ag is disposed.
    Type: Grant
    Filed: April 21, 2022
    Date of Patent: February 27, 2024
    Assignee: SAMSUNG ELECTRO-MECHANICS CO., LTD.
    Inventors: Chae Dong Lee, Og Soon Kim, Hye Won Kim, Jung Won Park
  • Patent number: 11597193
    Abstract: The present invention employs a polyimide film, which has a coefficient of thermal expansion (CTE) that is a negative number at a temperature equal to or greater than 350° C., as a debonding layer for separating a flexible substrate and a carrier substrate, and thus can easily separate a flexible substrate from a carrier substrate by using a detaching phenomenon caused by a difference in residual stress between the flexible substrate and the debonding layer after a high-temperature process for producing an element on the flexible substrate. Therefore, the present invention can separate the flexible substrate without causing chemical or physical damage to the element formed on the flexible substrate, thereby minimizing problems that may occur during a stripping process.
    Type: Grant
    Filed: September 11, 2019
    Date of Patent: March 7, 2023
    Assignee: LG CHEM, LTD.
    Inventors: Jinyoung Park, Jinho Lee, Chae Won Park
  • Publication number: 20220281817
    Abstract: The present invention relates to a benzamide derivative, a preparation method therefor, and a pharmaceutical composition comprising same as an active ingredient for prevention or treatment of cancer. The benzamide derivative provided in an aspect of the present invention can be used for preventing or treating cancer by suppressing EGFR mutation, and exhibits a remarkable synergy effect on anticancer activity when administered in combination with an EGFR antagonist such as Cetuximab, thus finding advantageous uses as an anticancer agent.
    Type: Application
    Filed: November 19, 2020
    Publication date: September 8, 2022
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Kwangho Lee, Jiwon Kim, Byoung Chul Cho, Gildon Choi, Jiyeon Yun, Chae Won Park, Krishna Babu Duggirala, Chong Hak Chae, Seo Young Lee, A Reum Go
  • Publication number: 20220249482
    Abstract: The present invention relates to a N2,N4-diphenylpyrimidin-2,4-diamine derivative, a method for preparing the same, and a pharmaceutical composition for the prevention or treatment of cancer, containing the same as an active ingredient. The derivative shows a relatively weak EGFR activity inhibitory effect on wild-type EGFR, a high inhibitory ability on EGFR mutation, and a high inhibitory ability on even FLT3 and FLT3 mutation, and thus, can be effectively used for the treatment of cancer with EGFR mutation or cancer with FLT3 or a mutation thereof, and the derivative shows a synergy effect at the time of combination administration, and thus can be effectively used for the treatment of combination administration.
    Type: Application
    Filed: February 18, 2022
    Publication date: August 11, 2022
    Inventors: Kwangho Lee, Inji Shin, Gildon Choi, Chong Hak Chae, Hyeon Jeong Choe, Myoung Eun Jung, Byeong Uk Jeon, Byoung Chul Cho, Chae Won Park, Hwan Kim, Krishna Babu Duggirala
  • Patent number: 11253516
    Abstract: The present invention relates to a N2,N4-diphenylpyrimidin-2,4-diamine derivative, a method for preparing the same, and a pharmaceutical composition for the prevention or treatment of cancer, containing the same as an active ingredient. The derivative shows a relatively weak EGFR activity inhibitory effect on wild-type EGFR, a high inhibitory ability on EGFR mutation, and a high inhibitory ability on even FLT3 and FLT3 mutation, and thus, can be effectively used for the treatment of cancer with EGFR mutation or cancer with FLT3 or a mutation thereof, and the derivative shows a synergy effect at the time of combination administration, and thus can be effectively used for the treatment of combination administration.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: February 22, 2022
    Assignee: Korea Research Institute of Chemical Technology
    Inventors: Kwangho Lee, Inji Shin, Gildon Choi, Chong Hak Chae, Hyeon Jeong Choe, Myoung Eun Jung, Byeong Uk Jeon, Byoung Chul Cho, Chae Won Park, Hwan Kim, Krishna Babu Duggirala
  • Publication number: 20210332029
    Abstract: The present invention relates to an isoindolin-1-on derivative, a method for preparing same, and a pharmaceutical composition comprising same as an effective component for preventing or treating tumors, wherein the isoindolin-1-on derivative exhibits a high inhibitory effect on EGFR mutations, and thus can be beneficially used for the treatment of EGFR-mutated tumors, and the isoindolin-1-on derivative exhibits a significant synergistic effect when co-administered, and thus can be beneficially used in concomitant therapy.
    Type: Application
    Filed: August 12, 2019
    Publication date: October 28, 2021
    Applicant: KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY
    Inventors: Kwangho Lee, Gildon Choi, Seoyoung Lee, Jiwon Kim, Byoung Chul Cho, Chae Won Park, Jiyeon Yun
  • Publication number: 20210313214
    Abstract: According to the present invention, a stack comprises, between a carrier substrate and a flexible substrate layer, a peeling power adjustment layer comprising polyimide, which has a refractive index higher than that of the flexible substrate layer, so that a flexible substrate can be more easily peeled from a carrier substrate layer, and thus a flexible element can be manufactured without damage to the element through a simpler process.
    Type: Application
    Filed: November 19, 2019
    Publication date: October 7, 2021
    Applicant: LG CHEM, LTD.
    Inventors: Chae Won PARK, Jinho LEE, Chan Hyo PARK
  • Publication number: 20210053328
    Abstract: The present invention employs a polyimide film, which has a coefficient of thermal expansion (CTE) that is a negative number at a temperature equal to or greater than 350° C., as a debonding layer for separating a flexible substrate and a carrier substrate, and thus can easily separate a flexible substrate from a carrier substrate by using a detaching phenomenon caused by a difference in residual stress between the flexible substrate and the debonding layer after a high-temperature process for producing an element on the flexible substrate. Therefore, the present invention can separate the flexible substrate without causing chemical or physical damage to the element formed on the flexible substrate, thereby minimizing problems that may occur during a stripping process.
    Type: Application
    Filed: September 11, 2019
    Publication date: February 25, 2021
    Applicant: LG CHEM, LTD.
    Inventors: Jinyoung PARK, Jinho LEE, Chae Won PARK
  • Publication number: 20200347184
    Abstract: A polyimide precursor solution containing a reaction product of tetracarboxylic acid anhydride and diamine in a molar ratio of 1:0.93 to 1:0.99. The polyimide precursor solution contains a polyimide precursor having a number average molecular weight of at least 38,000 g/mol and can thus produce a polyimide film having high heat resistance. A polyimide precursor solution having improved storage stability can be provided by quantifying the defoaming properties of the solution and controlling the content of bubbles. Moreover, a polyimide film produced therefrom has a reduced amount of bubbles in the film, and can thus suppress the formation of cracks that can form in an inorganic layer when forming a device.
    Type: Application
    Filed: September 26, 2019
    Publication date: November 5, 2020
    Applicant: LG CHEM, LTD.
    Inventors: Jinho LEE, Jinyoung PARK, Chae Won PARK, Chan Hyo PARK
  • Publication number: 20200179384
    Abstract: The present invention relates to a N2,N4-diphenylpyrimidin-2,4-diamine derivative, a method for preparing the same, and a pharmaceutical composition for the prevention or treatment of cancer, containing the same as an active ingredient. The derivative shows a relatively weak EGFR activity inhibitory effect on wild-type EGFR, a high inhibitory ability on EGFR mutation, and a high inhibitory ability on even FLT3 and FLT3 mutation, and thus, can be effectively used for the treatment of cancer with EGFR mutation or cancer with FLT3 or a mutation thereof, and the derivative shows a synergy effect at the time of combination administration, and thus can be effectively used for the treatment of combination administration.
    Type: Application
    Filed: December 6, 2018
    Publication date: June 11, 2020
    Inventors: Kwangho Lee, Inji Shin, Gildon Choi, Chong Hak Chae, Hyeon Jeong Choe, Myoung Eun Jung, Byeong Uk Jeon, Byoung Chul Cho, Chae Won Park, Hwan Kim, Krishna Babu Duggirala